<?xml version="1.0" encoding="UTF-8"?>
<p>When comparing the rates of previous illness, case-patients reported typical ZIKV symptoms more frequently than controls (OR: 9.58, 95% CI: 3.16–29.09) (
 <xref rid="pone.0230132.t004" ref-type="table">Table 4</xref>). Of GBS case-patients, 38.5% had evidence of ZIKV by PCR or IgM, compared to 30.1% of controls (OR: 1.26, 95% CI: 0.45–3.54). Case-patients were more likely than controls to have laboratory evidence of ZIKV infection in conjunction with a history of typical ZIKV symptoms (OR: 12.45, 95% CI: 1.45–106.64) (“symptomatic ZIKV”; 
 <xref rid="pone.0230132.t005" ref-type="table">Table 5</xref>).
</p>
